Cocrystal Formers (CCF) | Preparative Strategy | Key Findings | References |
Caffeine Isonicotine Nicotinamide 4-cyanopyridine | Solvent Crystallization | ・ Studies have shown that the solubility increases by 3 to 80 times after the formation of the cocrystal, and the peak time is reduced to 10 to 20 minutes. | [29] |
Proline | Solution Crystallization | ・ The highest solubility of myricetin-proline cocrystal in 40 minutes is 7.69 times that of myricetin flavone and 2.83 times that of myricetin-proline physical mixture. ・ The blood concentration of myricetin in the cocrystal is about 3.45 times higher than that of pure myricetin. | [30] |
4,4’-bipyridine | Solution Evaporation | ・ This work successfully demonstrates that the stoichiometric ratio could be inferred by analysing the possible number of intermolecular hydrogen bonds between flavonoids and amines. ・ The results showed that the cocrystal compound has a broader antibacterial activity than a single myricetin. | [15] |
API: Dihydromyricetin | Solution Crystallization | ・ This study demonstrates that the use of a highly soluble cocrystal along with an appropriate crystallization inhibitor is a potentially effective formulation strategy for improving oral bioavailability of poorly soluble BCS IV drugs. | [31] |
CCF: Caffeine; Urea | |||
Berberine chloride | Solution Crystallization | ・ The hydroxyl group of myricetin form O-H…Cl− with chloride anions, and the intermolecular interactions dominate the formation of cocrystal. ・ Cocrystals revealed low moisture adsorption up to 95% of relative humidity and enhanced solubility in water. | [32] |